Cosmetics

Hugel Achieves Record-Breaking Performance in 2024, Eyeing Global Expansion

mmyworldfix
mmyworldfixFeb 17, 2025

In a remarkable turn of events, Hugel, a company based in South Korea, has reported its most successful annual performance to date for the year 2024. The firm achieved an impressive net sales figure of KRW373.0 billion, with operating profits reaching KRW166.3 billion and net income standing at KRW142.4 billion. These figures represent respective increases of 16.7%, 41.2%, and 45.8% compared to the previous year. This exceptional growth can be attributed to robust demand in various markets and strategic product launches.

The cornerstone of Hugel's success lies in its botulinum toxin product, recognized globally under the brand name Letybo. Sales from this segment alone amounted to KRW203.2 billion, driven by significant traction in the Asia-Pacific region and new shipments to the United States. The company's hyaluronic acid fillers, marketed internationally as Revolax, also contributed substantially, generating KRW127.6 billion in revenue. This was bolstered by steady sales in China and expanding presence in Europe and the Middle East and North Africa (MENA) region.

Additionally, Hugel's cosmetics lines, WELLAGE and BYRYZN BR, witnessed a surge in popularity, recording a 37.8% increase in net sales to KRW36.9 billion. This growth was fueled by the introduction of new products and aggressive marketing efforts that resonated well with consumers.

Looking toward the future, Hugel plans to intensify its focus on the U.S. market with the launch of its botulinum toxin product. The company aims to secure a 10% market share in the United States within three years. Furthermore, it seeks to expand its footprint in the Gulf Cooperation Council (GCC) region, targeting a 30% market share in key MENA markets. These ambitious goals are supported by a strong consumer appetite for medical aesthetics and premium skincare, particularly in emerging markets like the Middle East.

Hugel's commitment to dermatology-led innovation, strategic partnerships, and targeted marketing campaigns positions it as a formidable player in the global beauty and personal care industry. The company's forward-looking strategies and robust financial performance underscore its potential to capture even larger segments of this rapidly growing market.

Related Articles

Hydrinity Expands to UK and Ireland Through Strategic Partnership
Cosmetics

Hydrinity Expands to UK and Ireland Through Strategic Partnership

Hydrinity Accelerated Skin Science is expanding into the UK and Ireland via a partnership with Unique Skin, a leading distributor in advanced aesthetics and skincare. This move targets a rapidly growing market projected to reach US$5 billion by 2025 and exceed US$8 billion by 2032, fueled by a 350% increase in cosmetic surgery and aesthetic clinics since 2010. Hydrinity’s clinically proven, minimalistic approach will be introduced to over 1,400 dermatologists, 740 plastic surgeons, and 4,600 clinics. The expansion leverages rising interest in medical-grade skincare and increasing disposable income, positioning Hydrinity to capitalize on the premium beauty market's growth.

mmyworldfixFeb 17, 2025
Biosphere Expands to Abu Dhabi: Pioneering Clean Beauty in the Middle East
Cosmetics

Biosphere Expands to Abu Dhabi: Pioneering Clean Beauty in the Middle East

Swiss premium skincare brand Biosphere has launched in Abu Dhabi, marking its official entry into the Middle Eastern market. Founded in 1992, Biosphere emphasizes clean beauty, educational engagement, and personalized guidance. To cater to local needs, the brand offers free online skin analysis and consultations. This expansion responds to the growing demand for premium, science-driven skincare in the region. Biosphere aims to provide a personalized, holistic approach to beauty, aligning with consumer preferences for tailored skincare solutions.

mmyworldfixFeb 17, 2025
Expanding Horizons: Allergan Aesthetics Unveils Plans for Advanced Training Centers
Cosmetics

Expanding Horizons: Allergan Aesthetics Unveils Plans for Advanced Training Centers

Allergan Aesthetics, an AbbVie company, plans to open three new Allergan Medical Institute (AMI) Training Centers in the U.S., starting with its Irvine, California headquarters in 2025, followed by locations in Atlanta and Austin. These centers will offer advanced, hands-on education for licensed aesthetic professionals, focusing on clinical techniques, business operations, safety, and efficacy in aesthetic procedures. The curriculum includes practical training, roundtable forums, and online resources, led by expert faculty under Medical Director Dr. Saami Khalifian. This expansion aims to enhance practitioner expertise and patient safety, addressing the growing global demand for advanced aesthetic treatments.

mmyworldfixFeb 17, 2025